TV 7613 Pill - green capsule/oblong
Pill with imprint TV 7613 is Green, Capsule/Oblong and has been identified as Aripiprazole 2 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Aripiprazole is used in the treatment of Bipolar Disorder; Autism; Depression; Agitated State; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Aripiprazole 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV 7613



Aripiprazole
- Imprint
- TV 7613
- Strength
- 2 mg
- Color
- Green
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- Inactive Ingredients
-
corn starch,
lactose monohydrate,
magnesium stearate,
aluminum oxide,
microcrystalline cellulose,
hydroxypropyl cellulose,
FD&C Blue No. 2,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00093-7613 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
42291-0133 (Discontinued) | AvKare, Inc. |
More about aripiprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,539)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Aripiprazole drug information
- Aripiprazole injection
- Aripiprazole (Intramuscular) (Advanced Reading)
- Aripiprazole lauroxil (Advanced Reading)
Other brands
Abilify, Abilify Maintena, Aristada, Abilify Asimtufii, ... +3 more
Professional resources
- Aripiprazole monograph
- Aripiprazole ODT (FDA)
- Aripiprazole Oral Solution (FDA)
- Aripiprazole Tablets (FDA)
Other brands
Abilify, Abilify Maintena, Aristada, Abilify Asimtufii, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.